Innoviva Specialty Announced That Positive Results From The Phase 3 Oral Zoliflodacin Trial Will Be Highlighted In An Oral Presentation At The European Society Of Clinical Microbiology And Infectious Disease Global Congress
Innoviva Specialty宣佈,將在歐洲臨床微生物學和傳染病學會全球大會上的口頭陳述中重點介紹3期口服佐利氟達辛試驗的積極結果